Journal of Anesthetics and Anesthesiology

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Perspective - Journal of Anesthetics and Anesthesiology (2023) Volume 5, Issue 2

Anesthetic considerations for patients with cardiac disease.

Xiaokan Teng *

Department of Anesthesiology

*Corresponding Author:
Xiaokan Teng a name="corr" id="corr">
Department of Anesthesiology
Hangzhou Medical College
Hangzhou, Zhejiang, China
E-mail: xiaokan@teng.cn

Received:07-Mar-2023, Manuscript No. AAAA-23-97656; Editor assigned:09-Mar-2023, PreQC No. AAAA-23-97656 (PQ); Reviewed:24-Mar-2023, QC No. AAAA-23-97656; Revised:29-Mar-2023, Manuscript No. AAAA-23-97656 (R); Published:09-Apr-2023, DOI:10.35841/ aaaa-5.2.145

Citation: Teng X. Anesthetic considerations for patients with cardiac disease. J Anesthetic Anesthesiol. 2023;5(2):145.

Visit for more related articles at Journal of Anesthetics and Anesthesiology

Abstract

  

Introduction

Anesthetic management of patients with cardiac disease requires a comprehensive evaluation of the patient's cardiac status, including preoperative optimization and risk stratification. Patients with cardiac disease are at an increased risk of perioperative morbidity and mortality, and careful attention must be paid to their hemodynamic status, fluid balance, and oxygenation during surgery. One of the key considerations in managing patients with cardiac disease is the choice of aesthetic agent. Some anesthetic agents can have adverse effects on the cardiovascular system, such as decreasing myocardial contractility, inducing hypotension, or causing arrhythmias. Therefore, the selection of the anesthetic agent should be based on the patient's underlying cardiac function, comorbidities, and the type of surgery being performed.[1].

In addition, perioperative monitoring is essential in patients with cardiac disease. This includes continuous Electro Cardio Graphy (ECG), invasive arterial blood pressure monitoring, and possibly central venous pressure monitoring. The goal of monitoring is to detect changes in the patient's cardiac status early and intervene promptly to prevent or treat any adverse events. Fluid management is another critical consideration for patients with cardiac disease. Adequate fluid resuscitation is essential to maintain cardiac output and prevent hypotension, but excessive fluid administration can lead to volume overload and congestive heart failure. Careful titration of fluids is necessary to maintain a balance between cardiac output and fluid status. Finally, postoperative management of patients with cardiac disease is also essential. Close monitoring in the postoperative period is necessary to detect and treat any postoperative complications promptly. Early mobilization, pulmonary hygiene, and adequate pain management are also essential to reduce the risk of postoperative complications [2].

In summary, anesthetic management of patients with cardiac disease requires a multidisciplinary approach and careful attention to the patient's cardiac function, perioperative monitoring, fluid management, and postoperative care. By following these principles, clinicians can reduce the risk of perioperative complications and improve patient outcomes. Cardiac anesthesia is a specialized field of anesthesia that focuses on administering anesthesia to patients undergoing cardiac surgery or procedures. The primary goal of cardiac anesthesia is to provide a safe, pain-free experience for the patient during the surgery while also closely monitoring the patient's vital signs and cardiac function. Cardiac anaesthesiologists are highly trained and experienced in managing the unique challenges of cardiac surgery, such as the use of cardiopulmonary bypass and other forms of mechanical support. They are also trained in the use of specialized monitoring equipment, such as transesophageal echocardiography, which allows them to closely monitor the patient's heart function during the surgery. During a cardiac surgery, the anaesthesiologist will administer a combination of drugs to induce and maintain anesthesia. These drugs may include opioids for pain control, muscle relaxants to facilitate the surgical procedure, and other medications to control blood pressure and heart function. The anaesthesiologist will also carefully monitor the patient's vital signs and cardiac function throughout the surgery to ensure the patient's safety [3].

After the surgery is complete, the anaesthesiologist will carefully manage the patient's transition out of anesthesia and into the recovery phase. They will continue to monitor the patient's vital signs and cardiac function, and will work closely with the surgical team to ensure the patient is stable and comfortable. Overall, cardiac anesthesia is a critical component of any cardiac surgery or procedure, and requires specialized knowledge, training, and experience to ensure the safety and well-being of the patient. Cardiac anesthesia is a specialized field of anesthesia that involves the administration of anesthesia during cardiac surgery. The goal of cardiac anesthesia is to provide optimal conditions for surgery, maintain hemodynamic stability, and ensure adequate perfusion of vital organs, particularly the heart and brain. The mechanism of action of cardiac anesthesia is complex and multifactorial, involving a combination of pharmacological and physiological effects. During cardiac anesthesia, the anaesthesiologist administers a combination of intravenous and inhaled anaesthetics to induce and maintain anesthesia. The choice of anesthetic agents depends on the patient's medical history, the type of cardiac surgery, and the anaesthesiologist’s preference. In addition to the anaesthetics, the anaesthesiologist may also administer other drugs such as muscle relaxants, opioids, and vasopressors to maintain hemodynamic stability and prevent complications. Cardiac anesthesia also involves the use of specialized monitoring equipment to assess the patient's hemodynamic status and vital organ function. This equipment includes invasive monitoring devices such as arterial and central venous catheters, as well as non-invasive monitoring devices such as electrocardiography, pulse oximetry, and transesophageal echocardiography [4].

The conclusion of cardiac anesthesia is a critical phase of the procedure that involves the safe emergence of the patient from anesthesia. The anaesthesiologist closely monitors the patient during this phase to ensure that the patient is breathing spontaneously, has adequate circulation, and is not experiencing any adverse effects of the anaesthetics. Once the patient is stable, the anaesthesiologist will transfer care to the Post-Anesthesia Care Unit (PACU) or Intensive Care Unit (ICU) where the patient will continue to receive monitoring and supportive care. In summary, cardiac anesthesia involves a complex combination of pharmacological and physiological interventions to provide optimal conditions for surgery and maintain hemodynamic stability. The conclusion of cardiac anesthesia is a critical phase that requires close monitoring to ensure the safe emergence of the patient from anesthesia [5].

References

  1. Zaouter C, Imbault J, Labrousse L, et al. . Association of robotic totally endoscopic coronary artery bypass graft surgery associated with a preliminary cardiac enhanced recovery after surgery program: A retrospective analysis. J Cardiothorac Vasc Anesth. 2015;29(6):1489-97.
  2. Indexed at, Google Scholar,Cross Ref

  3. Di Eusanio M, Alfonsi J, Berretta P, et al. . Ultra fast-track trans-axillary mini-aortic valve replacement. Ann Cardiothorac Surg. 2020;9(5):427.
  4. Indexed at, Google Scholar >,Cross Ref

  5. Cohen B, Turan A. Enhanced recovery after cardiac surgery-Is evidence still necessary?. J Clin Anesth. 2019;54:171-2.
  6. Indexed at, Google Scholar, Cross Ref

  7. Williams JB, McConnell G, Allender JE, et al. One-year results from the first US-based enhanced recovery after cardiac surgery (ERAS Cardiac) program. J Thorac Cardiovasc Surg. 2019;157(5):1881-8.
  8. Indexed at, Google Scholar, Cross Ref

  9. Grant MC, Isada T, Ruzankin P, et al. Results from an enhanced recovery program for cardiac surgery.. Thorac Cardiovasc Surg. 2020;159(4):1393-402.
  10. Indexed at, Google Scholar, Cross Ref

Get the App